Presented: May 5, 2016
Speaker: Carol A. Langford, MD, MHS, FACP
Director, Center for Vasculitis Care and Research
Click here to download the presentation.
In this webinar, in observance of the Vasculitis Foundation’s 30th Anniversary, Dr. Langford discusses the progress and challenges for patients with vasculitis and physicians treating them over the past 30 years. In addition, Dr. Langford reviews advances made in vasculitis research, and what it means for patients.
From 1994 to 2004, Dr. Langford was a senior investigator within the Immunologic Diseases Section of the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH). At the NIH, Dr. Langford’s research focused on vasculitic diseases, where she was Principal Investigator for 9 vasculitis-related protocols. In 2004, Dr. Langford joined Cleveland Clinic to become Director of the Center for Vasculitis Care and Research within the Department of Rheumatic and Immunologic Diseases. Her work has continued to focus on patient care and research in vasculitic diseases, including granulomatosis with polyangiitis (Wegener’s), microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis (Churg-Strauss), polyarteritis nodosa, giant cell arteritis, Takayasu’s arteritis, and other forms of vasculitis.
In 2007, she was awarded an important research contract from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the NIH for concurrent pilot studies in giant cell arteritis and Takayasu’s arteritis. She has also received funding from the Rare Diseases Clinical Research Network of the NIH to conduct a pilot study in granulomatosis with polyangiitis that has led to a multicenter international randomized trial. Dr. Langford is an active member of the American College of Rheumatology, where she has served on several committees.
Click here to read her complete biography and to learn about the Cleveland Clinic.